4//SEC Filing
VAGELOS P ROY 4
Accession 0001883850-22-000139
CIK 0000872589other
Filed
Dec 19, 7:00 PM ET
Accepted
Dec 20, 5:44 PM ET
Size
9.8 KB
Accession
0001883850-22-000139
Insider Transaction Report
Form 4
VAGELOS P ROY
Director
Transactions
- Award
Common Stock
2022-12-16+1,651→ 324,083 total - Award
Non-Qualified Stock Option (right to buy)
2022-12-16+16,254→ 16,254 totalExercise: $726.53Exp: 2032-12-16→ Common Stock (16,254 underlying)
Holdings
- 126,043(indirect: by CLAT)
Common Stock
- 2,102(indirect: By 401(k))
Common Stock
- 23,461(indirect: By Trust)
Common Stock
- 3,609(indirect: By Trust)
Common Stock
Footnotes (3)
- [F1]Reflects an acquisition of time-based vesting restricted stock units each representing a contingent right to receive one share of the Company's common stock.
- [F2]By trusts for the benefit of nine grandchildren of the reporting person, each of which holds 401 shares of Company stock. The reporting person and/or the spouse of the reporting person is the trustee of each such trust.
- [F3]The stock option award vests in four equal annual installments, commencing one year after the date of grant.
Documents
Issuer
REGENERON PHARMACEUTICALS, INC.
CIK 0000872589
Entity typeother
IncorporatedMD
Related Parties
1- filerCIK 0001013064
Filing Metadata
- Form type
- 4
- Filed
- Dec 19, 7:00 PM ET
- Accepted
- Dec 20, 5:44 PM ET
- Size
- 9.8 KB